InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
3
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-30.3%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the detailed record of transactions filed by Vos Ellen O'Connor, 董事. Director active across 3 companies, notably OptimizeRx Corp. In total, 17 filings have been recorded. Breakdown: 3 buys · 0 sell. Total volume traded: €150k. History available since 30 June 2021. The latest transaction was disclosed on 11 June 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Vos Ellen O'Connor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报17 总计
9,868 股0Common StockSEC:0001628280-25-031019:0
5,312 股0Common StockSEC:0001641172-25-014017:0
5,313 股0Common StockSEC:0001641172-25-002278:0
5,312 股0Common StockSEC:0001562180-25-000277:0
5,313 股0Common StockSEC:0001562180-24-007233:0
16,593 股0Common StockSEC:0000950170-24-096244:0
3,268 股Common StockSEC:0000950170-24-082709:0
10,061 股0Common StockSEC:0001628280-24-027715:0
4,637 股0Common StockSEC:0001628280-23-029926:0
3,769 股@ US$3.98100.0% 占其流量Common StockSEC:0000926617-23-000061:0
标准退出：2023年10月22日 (T+90)
29,109 股0Common StockSEC:0001562180-23-004817:0
657 股0Common StockSEC:0001628280-23-010319:0
409 股0Common StockSEC:0001628280-23-000213:0
334 股0Common StockSEC:0001628280-22-025807:0
500 股@ US$15.91100.0% 占其流量Common StockSEC:0001213900-22-049031:0
标准退出：2022年11月14日 (T+90)
55,555 股@ US$2.70100.0% 占其流量Common StockSEC:0001019056-21-000555:0
标准退出：2022年1月26日 (T+90)
407 股0Common StockSEC:0001213900-21-035082:0
17 条申报中的 17 条
About Vos Ellen O'Connor
Vos Ellen O'Connor is Chief Executive Officer and Director. The file shows 17 filings in total, and across the 17 recent filings held, buys total 149764 EUR and sells total 0 EUR, between 2021-06-30 and 2025-06-12. The most common transaction nature is Option exercise, and the main recent filings concern Modular Medical, Inc., Aspira Women's Health Inc., and OptimizeRx Corp.
